Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron).

Article Details

Citation

Heianna J, Miyauchi T, Endo W, Miura N, Terui K, Kamata S, Hashimoto M

Tumor regression of multiple bone metastases from breast cancer after administration of strontium-89 chloride (Metastron).

Acta Radiol Short Rep. 2014 May 10;3(4):2047981613493412. doi: 10.1177/2047981613493412. eCollection 2014 May.

PubMed ID
25298863 [ View in PubMed
]
Abstract

We report a case of tumor regression of multiple bone metastases from breast carcinoma after administration of strontium-89 chloride. This case suggests that strontium-89 chloride can not only relieve bone metastases pain not responsive to analgesics, but may also have a tumoricidal effect on bone metastases.

DrugBank Data that Cites this Article

Drugs